Faron Pharmaceuticals Oy

FPHAF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$26-$31-$29-$21
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$2$1$1
Change in WC-$5$3$5-$2
Other Non-Cash$7$1-$1-$1
Operating Cash Flow-$23-$24-$23-$22
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0-$0$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.-$0-$1$10$1
Stock Issued$32$26$13$26
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$6-$1-$0-$1
Financing Cash Flow$26$24$23$26
Forex Effect$0-$0$0-$0
Net Chg. in Cash$3-$0$0$3
Supplemental Information
Beg. Cash$7$7$7$4
End Cash$10$7$7$7
Free Cash Flow-$23-$24-$23-$23
Faron Pharmaceuticals Oy (FPHAF) Financial Statements & Key Stats | AlphaPilot